Results 31 to 40 of about 87,371,428 (168)

Recovery capital among people receiving treatment for opioid use disorder with buprenorphine

Harm Reduction Journal, 2021
Background Recovery is a multidimensional process that includes health, quality of life, and citizenship. Recovery capital is a strengths-based concept representing the sum of an individual’s resources that support recovery.
Anna Beth Parlier-Ahmad, Mishka Terplan, Dace S. Svikis, Laura Ellis, Caitlin E. Martin   +4 more
doaj   +1 more source

Integrating opioid use disorder treatment into primary care settings.

, 2023
Importance: Medication for opioid use disorder (MOUD) (eg, buprenorphine and naltrexone) can be offered in primary care, but barriers to implementation exist.
Heald, Ashley, Ratzliff, Anna D, Williams, Emily C, Saxon, Andrew J, Chen, Jessica, Merrill, Joseph O, Austin, Elizabeth J, Briggs, Elsa S, Curran, Geoffrey M, Ferro, Lori, Fortney, John C, Barry, Paul   +11 more
core   +1 more source

Patient decision aid for medication treatment for opioid use disorder (PtDA-MOUD): Rationale, methodology, and preliminary results. [PDF]

, 2020
Background and aimsAs treatment for opioid use disorder (OUD) expands within general healthcare settings such as primary care, mechanisms to facilitate decision-making processes are increasingly necessary.
Yoo, Caroline, Valdez, Jonathan, Hser, Yih-Ing, Zhu, Yuhui, Mooney, Larissa J, Cousins, Sarah J   +5 more
core   +1 more source

Trends in Opioid Medication Adherence During the COVID-19 Pandemic: Retrospective Cohort Study

JMIR Public Health and Surveillance, 2023
BackgroundThe recent pandemic had the potential to worsen the opioid crisis through multiple effects on patients’ lives, such as the disruption of care. In particular, good levels of adherence with respect to medication for opioid
Amir Marashi, David Warren, Gary Call, Mark Dras   +3 more
doaj   +1 more source

Activity space in adults receiving medication for opioid use disorder (MOUD)

, 2022
This study aims to determine changes in the geographical activity space of adults as they stabilize on treatment with medication for opioid use disorder (MOUD).
Marina Kheyfets, Leigh Panlilio, Jeffrey Feldman, Jeffrey Rogers, David Epstein, Albert Burgess-Hull   +5 more
core   +1 more source

Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugs

Substance Abuse Treatment, Prevention, and Policy, 2023
Background Medications for opioid use disorder (MOUD; methadone, buprenorphine, naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal overdoses.
Jaclyn M. W. Hughto, Abigail Tapper, Sabrina S. Rapisarda, Thomas J. Stopka, Wilson R. Palacios, Patricia Case, Joseph Silcox, Patience Moyo, Traci C. Green   +8 more
doaj   +1 more source

Antepartum multidisciplinary approach improves postpartum pain scores in patients with opioid use disorder

Journal of Perinatal Medicine
Pregnancies affected by opioid use disorder (OUD) face difficulties with postpartum pain control. This study aims to determine if prenatal anesthesia consultation for patients on medication for opioid use disorder (MOUD) affects maternal postpartum pain ...
Yang Tiffany, Stetler Emily, Garretto Diana, Herrera Kimberly, Garry David, Heiselman Cassandra   +5 more
doaj   +1 more source

The effect of a pilot brief educational intervention on preferences regarding treatments for opioid use disorder

Drug and Alcohol Dependence Reports
Purpose: Negative perceptions around medications for opioid use disorder (MOUD) amongst the public could deter patients with opioid use disorder (OUD) from engaging with MOUD.
Emaun Irani, Colin Macleod, Stephanie Slat, Adrianne Kehne, Erin Madden, Kaitlyn Jaffe, Amy Bohnert, Pooja Lagisetty   +7 more
doaj   +1 more source

Joint associations of recovery capital and polygenic risk with electronic health record observed remission and relapse in substance use disorder: Longitudinal evidence from the All of Us research program

Addiction, EarlyView.
Abstract Background and aims Recovery capital and genetic liability may be related to substance use disorder (SUD) remission through psychosocial and biologic pathways, but their joint association with remission course remains poorly understood. This question is clinically important because people entering remission differ in recovery resources and ...
Janaka V. Kosgolla, Douglas C. Smith
wiley   +1 more source

Variation in 90‐day substance use disorder‐related acute care events across United States opioid treatment programs: A Medicaid claims analysis

Addiction, EarlyView.
Abstract Background and aims Creating and tracking quality measures has improved outcomes in many areas of healthcare; however, quality measures specific to opioid treatment programs (OTPs) have not yet been developed. Based on the success seen in other fields, introducing quality measures in OTPs should help enhance positive outcomes and decrease ...
Barrett Wallace Montgomery, Tami L. Mark, Thanh Lu, William N. Dowd, Dylan DeLisle, Kathryn N. Burke, Daniel H. Barch, Gary A. Zarkin   +7 more
wiley   +1 more source